More children vaccinated against mumps, measles, rubella and HPV The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.
Transfer models for harmful substances in animal feed online now RIVM and Wageningen Food Safety Research have made five feed-food transfer models available to calculate how many harmful substances in animal feed end up in animal-based foods.
Essential to keep a close eye on roll out of 5G The extent to which people are exposed to electromagnetic fields from individual 5G antennas and telephones is below the limits recommended by the European Union.
Control measures against the spread of Legionella from wastewater treatment plants Wastewater treatment plants (WWTPs) may spread Legionella via the air and cause pneumonia if people inhale them.
Research: HPV vaccine is safe RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.
New method for toxicological assessment of perfluoro mixtures Perfluoro (PFAS) is a group of substances that contains PFOS, PFOA and GenX. Perfluoro substances often occur as pollution in ground water and drinking water.
New Director-General Hans Brug starts at RIVM After the approval of his nomination on the proposal of Minister Ollongren of the Interior and Kingdom Relations on June 1 of this year, Professor J.
Meningococcal type W most notable infectious disease in 2017 The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a
Large increase in legionellosis in the Netherlands The Municipal Public Health Services (GGD) received 561 reports of legionellosis over the past year. Never before has RIVM registered as many reports of this disease as in the past year.